Loading...
OTC Markets
Totals
Securities
12,439
Dollar Vol
$3.6B
Share Vol
5.2B
Trades
469,230

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

ITNS
ITonis, Inc.

Common Stock
ITonis, Inc. Company Logo

25422 Trabuco Road

Suite 105-297

Lake Forest, CA 92630

Business Description
The Company operates as a holding company and has embarked upon an aggressive plan to acquire high growth entrepreneurial companies that have established or are expected to establish themselves as leaders and successful enterprises in various market niches.
Financial Reporting
Reporting Status
Alternative Reporting Standard
Audited Financials
Unaudited
CIK
0001360184
Fiscal Year End
11/30
Company Officers & Contacts
Mark Cheung
CEO

Board of Directors
Mark Cheung
CEO

Sam Joudeh

Other Company Insiders

None

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Jill Twombly
Securities Counsel
Law Office of Mark H. Cheung

25422 Trabuco Road

Suite 105-297

Lake Forest, CA 92630

Profile Data
SIC - Industry Classification
8999 - Services, misc
Incorporation Information
NV, US, 2005
Employees
3 as of 05/02/2011
Shell
No
Products and Services

In 2012, the Company launched a new Itonis Pharmaceuticals division to produce and market over the counter and prescription homeopathic preparations to treat both common ailments and chronic diseases. The Company has launched the retails sale of the Emesyl® nausea relief product. The Company has identified the market for its Emesyl® product line as the general public who suffers from nausea. Emesyl® is available for purchase at https://www.amazon.com/dp/B00U20H3KI and www.Emesyl.com.

Company Facilities

The Company's corporate headquarters are located in approximately 1,728 square feet of leased office space in Lake Forest, California pursuant to a lease that expires in September 2023.

Companies that may have limited disclosure or financial information publicly available, but meet a minimum requirement for public quoting under Rule 15c2-11.
Limited Information Icon
Pink Limited Information
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers